Researchers Explore Gene Therapy to Restore Vision After Stroke
About one-third of stroke survivors experience some degree of vision loss.
For many patients, the condition can be life-changing. Vision often does not fully recover, and few effective treatment options exist.
New research from teams at Purdue University and Jinan University offers hope that gene therapy could help restore vision lost after a stroke.
A New Approach to Restoring Vision After Stroke
A stroke occurs when blood flow to part of the brain is interrupted.
Without oxygen, brain cells begin to die. In many cases, a blocked artery causes the damage.
Strokes often affect movement and coordination. They can also damage brain areas involved in vision.
The brain sometimes rewires itself after injury and restores some lost function. However, recovery is often incomplete.
One major challenge is that neurons do not naturally regenerate after they die.
As a result, communication pathways within the brain can remain disrupted long after the stroke occurs.
Turning Support Cells Into New Neurons
Researchers led by Alexander Chubykin at Purdue University and Gong Chen at Jinan University are testing a different strategy.
Instead of transplanting stem cells, they are reprogramming glial cells already present in the brain.
Glial cells normally support and protect neurons. The researchers have found a way to convert some of these cells into new neurons.
The newly created neurons may help rebuild connections that strokes destroy.
By generating replacement neurons inside the brain, researchers hope to restore communication between damaged neural networks.
The approach could bypass some challenges associated with cell transplantation.
“We can watch the mice get their vision back,” said Dr. Chubykin. “We don’t have to implant new cells, so there’s no immunogenic rejection.”
He added that the process may prove simpler than traditional cell transplantation approaches and could reduce additional tissue damage.
Expanding the Possibilities for Stroke Recovery
The findings, published in Frontiers in Cell and Developmental Biology, suggest the technique may help restore visual function after stroke.
Researchers believe the approach could have broader applications.
Many of the same principles that govern vision recovery also apply to motor function.
If scientists can successfully rebuild damaged neural circuits, they may eventually help patients recover movement as well as vision.
Vision provides a useful starting point because researchers can measure visual improvements more precisely than motor recovery.
The teams are now using advanced imaging technologies to study how the reprogrammed neurons function in living mice.
Looking Ahead
While the work remains in the preclinical stage, the results have generated excitement among researchers.
Additional studies will determine whether the approach remains safe and effective over time.
If future experiments continue to produce positive results, researchers could eventually move the therapy toward human clinical trials.
The work highlights the growing potential of regenerative medicine to repair damage once considered permanent.
CIRM continues to support that goal through investments in clinical trials for both vision restoration and stroke recovery.
Each advance brings researchers closer to developing therapies that can help patients regain function, independence, and quality of life after a stroke.